Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,400.00
-185.00 (-4.03%)
At close: Aug 1, 2025, 3:30 PM KST
-4.03%
Market Cap37.56B
Revenue (ttm)389.96M
Net Income (ttm)-1.21B
Shares Out8.54M
EPS (ttm)-876.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,716
Average Volume1,403
Open4,600.00
Previous Close4,585.00
Day's Range4,225.00 - 4,600.00
52-Week Range2,565.00 - 9,000.00
Beta0.88
RSI43.91
Earnings Daten/a

About United States Steel

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.